Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Equity Ratio (2016 - 2025)

Nutex Health's Equity Ratio history spans 16 years, with the latest figure at 0.4 for Q2 2025.

  • For Q2 2025, Equity Ratio rose 106.28% year-over-year to 0.4; the TTM value through Jun 2025 reached 0.4, up 106.28%, while the annual FY2024 figure was 0.29, 44.84% up from the prior year.
  • Equity Ratio for Q2 2025 was 0.4 at Nutex Health, up from 0.34 in the prior quarter.
  • Across five years, Equity Ratio topped out at 18.57 in Q3 2021 and bottomed at 0.18 in Q3 2024.
  • The 5-year median for Equity Ratio is 0.3 (2022), against an average of 1.63.
  • The largest YoY upside for Equity Ratio was 2307.72% in 2021 against a maximum downside of 99.94% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.49 in 2021, then crashed by 42.59% to 0.28 in 2022, then decreased by 28.73% to 0.2 in 2023, then surged by 44.84% to 0.29 in 2024, then soared by 39.23% to 0.4 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Equity Ratio are 0.4 (Q2 2025), 0.34 (Q1 2025), and 0.29 (Q4 2024).